Peter Atadja

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Peter Atadja

Earlier roles on record: Board Member at Traws Pharma, Inc. (TRAW) until April 1, 2024. Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that Peter Atadja resigned as Board, effective April 1, 2024.

“accepted the resignations of Dr. Steven M. Fruchtman, Peter Atadja, Jerome Groopman, and Viren Mehta from the Board”

Traws Pharma, Inc. Form 8-K, filed April 4, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Peter Atadja's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Traws Pharma, Inc. (TRAW)
Board Member

Proxy statement

Start not stated–2024-04-01
Traws Pharma, Inc. (TRAW)
Board Member

Proxy statement

Start not stated–2024-04-01

Company network

Recorded roles and call appearances connecting this person to public companies.

Traws Pharma, Inc.

TRAW

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Board Traws Pharma, Inc. (TRAW)
2024-04-01